DDRI-18
DDRI-18 is a novel small molecule inhibitor that regulates the DNA damage response with sensitizing and anticancer activities, inhibits non-homologous end-joining (NHEJ) DNA repair and enhances the cytotoxicity of anticancer DNA damage compounds.
Product Specifications
CAS Number
4402-18-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
416.48
Molecular Formula
C26H20N6
Notes
Research use only, not for human use.
Receptor
DNA/RNA Synthesis
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15275138 1 Vial
Lentiviral mouse Fos shRNA (UAS) - Lentiviral mouse Fos shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
MBS7112717-01 0.02 mg (E-Coli)
Recombinant Serratia marcescens Metallo-beta-lactamase type 2, partial
Sign In for Pricing
View Details 
MBS7112717-02 0.1 mg (E-Coli)
Recombinant Serratia marcescens Metallo-beta-lactamase type 2, partial
Sign In for Pricing
View Details MBS7112717-03 1 mg (E-Coli)
Recombinant Serratia marcescens Metallo-beta-lactamase type 2, partial
Sign In for Pricing
View Details MBS7112717-04 5x 1 mg (E-Coli)
Recombinant Serratia marcescens Metallo-beta-lactamase type 2, partial
Sign In for Pricing
View Details 
MBS1231855-01 0.02 mg (E-Coli)
Recombinant Shigella flexneri Positive transcription regulator evgA (evgA)
Sign In for Pricing
View Details